Literature DB >> 30768935

Increased risk of osteoporosis with hysterectomy: A longitudinal follow-up study using a national sample cohort.

Hyo Geun Choi1, Yoon Jung Jung2, Suk Woo Lee3.   

Abstract

BACKGROUND: Premenopausal hysterectomy is associated with a decreased ovarian reserve, follicular atresia, and subsequently reduced long-term estrogen secretion. Therefore, women who undergo hysterectomy will experience greater gradual bone mineral loss than women with an intact uterus and have an increased risk of osteoporosis.
OBJECTIVE: This study aimed to evaluate the association between hysterectomy without/with bilateral oophorectomy and the occurrence of osteoporosis using a national sample cohort from South Korea. STUDY
DESIGN: Using the national cohort study from the Korean National Health Insurance Service, we extracted data for patients who had undergone hysterectomy (n=9082) and for a 1:4 matched control group (n=36,328) and then analyzed the occurrence of osteoporosis. The patients were matched according to age, sex, income, region of residence, and medical history. A Cox proportional hazards model was used to analyze the hazard ratios and 95% confidence intervals. Subgroup analyses were performed based on age and bilateral oophorectomy status. The age of the participants was defined as the age at the time of hysterectomy.
RESULTS: The adjusted hazard ratio for osteoporosis was 1.45 (95% confidence interval, 1.37-1.53, P<.001) in the hysterectomy group. The adjusted hazard ratios for osteoporosis in the different age subgroups of this group were 1.84 (95% confidence interval, 1.61-2.10) for ages 40-44 years, 1.52 (95% confidence interval, 1.39-1.66) for ages 45-49 years, 1.44 (95% confidence interval, 1.28-1.62) for ages 50-54 years, 1.61 (95% confidence interval, 1.33-1.96, all P<.001) for ages 55-59 years, and 1.08 (95% confidence interval, 0.95-1.23, P=.223) for ages ≥60 years. The adjusted hazard ratios for osteoporosis according to hysterectomy/oophorectomy status were 1.43 (95% confidence interval, 1.34-1.51) in the hysterectomy without bilateral oophorectomy group and 1.57 (95% confidence interval, 1.37-1.79) in the hysterectomy with bilateral oophorectomy group.
CONCLUSION: The occurrence of osteoporosis was increased in patients who had undergone hysterectomy compared with that in matched control subjects regardless of bilateral oophorectomy status.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Korea; cohort studies; hysterectomy; osteoporosis

Mesh:

Year:  2019        PMID: 30768935     DOI: 10.1016/j.ajog.2019.02.018

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Adverse childhood experiences are associated with increased risk of hysterectomy and bilateral oophorectomy: A national retrospective cohort study of women in England.

Authors:  Panayotes Demakakos; Andrew Steptoe; Gita D Mishra
Journal:  BJOG       Date:  2022-02-08       Impact factor: 7.331

2.  Hysterectomies are associated with an increased risk of osteoporosis and bone fracture: A population-based cohort study.

Authors:  Ying-Ting Yeh; Pei-Chen Li; Kun-Chi Wu; Yu-Cih Yang; Weishan Chen; Hei-Tung Yip; Jen-Hung Wang; Shinn-Zong Lin; Dah-Ching Ding
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

Review 3.  What We Know about the Long-Term Risks of Hysterectomy for Benign Indication-A Systematic Review.

Authors:  Obianuju Sandra Madueke-Laveaux; Amro Elsharoud; Ayman Al-Hendy
Journal:  J Clin Med       Date:  2021-11-16       Impact factor: 4.241

4.  Incidence of Depression after Traumatic Brain Injury: A Nationwide Longitudinal Study of 2.2 Million Adults.

Authors:  Yoonjeong Choi; Eun Young Kim; Jiyu Sun; Han-Kyoul Kim; Ye Seol Lee; Byung-Mo Oh; Hye Yoon Park; Ja-Ho Leigh
Journal:  J Neurotrauma       Date:  2022-02-02       Impact factor: 5.269

5.  MYLK and PTGS1 Genetic Variations Associated with Osteoporosis and Benign Breast Tumors in Korean Women.

Authors:  Hye-Won Cho; Hyun-Seok Jin; Yong-Bin Eom
Journal:  Genes (Basel)       Date:  2021-03-06       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.